By Justin Healy, ComeLook.org
“We, as consultants in sexual health, have been told to say nothing publicly that would damage the current (HPV) vaccine programme..”
This week, in a BBC website article co-authored with Dr Steve Taylor , consultant physician Dr Colm O’Mahony points out the superiority of the Merck HPV vaccine ‘Gardasil’ over it’s GSK competition ‘Cervarix’ (which is currently administered as part of the HPV mass vaccination program in the UK).
The NHS contract for the vaccine program comes up for renewal this year and Dr O’Mahony argues that the Merck product should be chosen instead as it also protects against genital warts while the GSK variant does not.
In this latest BBC article Dr O’Mahony admits to having to be ‘circumspect’ when speaking on the subject: “We, as consultants in sexual health, have been told to say nothing publicly that would damage the current (HPV) vaccine programme..”. Apparently this explains the absense of any stated doubts among these ‘consultants’ regarding the safety of either HPV vaccine. There have been 1300 reported adverse reactions to Cervarix so far in the UK, many of them debilitating, as highlighted in a recent Daily Mail article on five such affected girls. The vaccination program was imposed on UK schools followed a government ‘information’ campaign which exaggerated the benefits of the vaccine without communicating the known safety risks.